Diversity in Medicine: Are There Racial Differences in Treatment Out…

Houston Methodist DeBakey Heart and Vascular Center

C. Yancy

Intravenous Iron for Heart Failure: Where Is the Evidence?

28th Annual Heart Failure 2024: An Update on Therapy

I. Pina

Overview of Iron Deficiency in Heart Failure & Recognizing Iron Defi…

ACHL

M. Vaduganathan

Managing Amyloidosis in 2024: Diagnosis and Treatment

Indy Hematology Review

M. Gertz

Treatment of Iron Deficiency Across the Heart Failure Spectrum

ACHL

S. Gale

Overview of Monoclonal Gammopathies From MGUS to Smoldering Myeloma

Fred Hutch 14th Annual Comprehensive Hematology & Oncology Review Course

M. Kwok

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Indy Hematology Review

R. Birhiray

Cardiotoxicity in Breast Cancer – Case Discussion

University of Colorado Department of Medicine

L. Kondapalli

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

POEMS Syndrome Management

MyCancerHaven

R. Vij, D. Dingli

Lung Involvement in Amyloidosis

Houston Methodist

H. Huang

Cardio-Oncology: Definitions and Scope

University of Colorado Department of Medicine

L. Kondapalli

How to Minimize and Manage Checkpoint Inhibitors Adverse Cardiac Eve…

University of Colorado Department of Medicine

L. Kondapalli

Experts Discuss the Management of Monoclonal Gammopathy of Renal Sig…

MyCancerHaven

R. Vij, N. Leung

Management of AL Amyloidosis

GRACE

S. Rajeeve

Updates on AL Amyloidosis Treatment: What’s New in 2024

Dana-Farber Cancer Institute

G. Bianchi

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Indy Hematology Review

M. Gertz

The PRONOUNCE and HERO Trials: The Cardiovascular Safety of Degareli…

Przemyslaw Twardowski

"You Have AL-Amyloidosis": Counseling Newly Diagnosed Patients

Morie Gertz

2023 Update on Cardiac Amyloid

MUSC Cardiology

J. Griffin